Is SCHE a Buy? What to Consider in 2026

Short answer

The case for SCHE is simple: low-cost, diversified exposure to FTSE Emerging at a 0.06% expense ratio, anchored by names like TSM, TCEHY, BABA. If that is the exposure you want and you do not already own most of it through another fund, SCHE is a strong core holding. The catch is concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want FTSE Emerging and at what cost. Not a recommendation; Walnut is not an investment adviser.

What are you buying with SCHE?

Tracks the FTSE Emerging Index, which covers roughly 1,900 large and mid-cap stocks across emerging markets only. China, Taiwan, India, and Brazil lead the country weights, with no US and no developed-international exposure. Because it follows FTSE methodology, it excludes South Korea, which FTSE classifies as developed, the same approach Vanguard's VWO takes and the main structural difference from MSCI-based funds like IEMG.

Largest holdings (approximate as of early 2026; verify on Schwab's fund page):

RankTickerCompany% of SCHE
1TSMTaiwan Semiconductor~7.0%
2TCEHYTencent~4.5%
3BABAAlibaba~2.7%
4RELIANCEReliance Industries~1.6%
5PDDPDD Holdings~1.4%
6INFYInfosys~1.2%
7HDBHDFC Bank~1.1%
8MELIMercadoLibre~1.0%
9MPNGYMeituan~0.9%
10IBNICICI Bank~0.8%

What's the case for SCHE?

SCHE is the Schwab Emerging Markets Equity ETF, a fund that tracks the FTSE Emerging Index at a 0.06% expense ratio. It holds roughly 1,900 stocks across emerging markets only, with no US and no developed-market exposure: China, Taiwan, India, and Brazil lead the country mix (TSM, TCEHY, BABA, Reliance at the top). Like VWO, it uses FTSE methodology, so it excludes South Korea (which FTSE classifies as developed), unlike IEMG, which follows an MSCI index that includes Korea. It is the Schwab-house emerging-markets fund, often chosen by investors already in the Schwab ecosystem.

In its favour: it gives you FTSE Emerging exposure in one ticker at a 0.06% expense ratio, which is simple to hold and cheap to own.

What should you weigh before buying SCHE?

  • Cost vs alternatives: 0.06% is the fee; compare it to funds tracking a similar index.
  • Concentration: check how much of SCHE sits in its largest holdings (TSM, TCEHY, BABA).
  • Overlap: if you already own a broad-market fund, you may already hold much of this.
  • Tracking scope: SCHE only gives you FTSE Emerging; it will not capture what sits outside that index.

How do you decide if SCHE is a buy?

The useful question is rarely “will SCHE go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how SCHE would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.

The bottom line on SCHE

The bottom line: SCHE is a low-cost core building block for FTSE Emerging exposure, not a tactical bet on a single name. If you want FTSE Emerging exposure and the 0.06% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.

Build a portfolio around SCHE with Walnut

Use SCHE as your core holding, then let Walnut's AI propose thematic satellites: AI infrastructure, dividend growth, clean energy, whatever you believe in. Connect your broker, build the basket in conversation, track it as one unit.

FAQ

Is SCHE a good ETF to buy?

+

Walnut is informational, not investment advice. Whether SCHE fits depends on your goals, time horizon, and what you already hold. It tracks FTSE Emerging at a 0.06% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.

What does SCHE actually hold?

+

SCHE tracks FTSE Emerging. Its largest positions include TSM, TCEHY, BABA, RELIANCE, PDD and others (approximate, verify on Schwab's fund page). The holdings are what you are really buying, not the ticker.

What is SCHE's expense ratio?

+

0.06% as of early 2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.

Does SCHE pay a dividend?

+

SCHE distributes a dividend with an approximate yield of ~2.7% (early 2026). See the SCHE dividend page for how distributions work. Verify the current figure with Schwab.

What are the risks of buying SCHE?

+

Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether FTSE Emerging matches the exposure you actually want. SCHE only gives you FTSE Emerging, not what sits outside it.

How do I decide if SCHE is right for me?

+

Start from your goal, then check four things: what SCHE holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.

Walnut is informational, not investment advice. Figures are approximations stamped to early 2026; verify current data with Schwab or your broker. Nothing here is a recommendation to buy, sell, or hold any security.

    Is SCHE a Buy? What to Consider in 2026, Walnut